# EDGAR Filing Document

**Accession Number:** 0001880438
**File Stem:** 0000000000-26-003830
**Filing Date:** 2026-4
**Character Count:** 2173
**Document Hash:** 4ed8039e4ae134df1bac544d2c25e95f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-003830.hdr.sgml**: 20260526

**ACCESSION NUMBER**: 0000000000-26-003830

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260415

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AN2 Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001880438
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 820606654
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-294956

**BUSINESS ADDRESS:**
- **STREET 1:** 1300 EL CAMINO REAL, SUITE 100
- **CITY:** MENLO PARK
- **STATE:** CA
- **ZIP:** 94025
- **BUSINESS PHONE:** (650) 331-9090

**MAIL ADDRESS:**
- **STREET 1:** 1300 EL CAMINO REAL, SUITE 100
- **CITY:** MENLO PARK
- **STATE:** CA
- **ZIP:** 94025
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001193125-26-149869

## Text-Extract

```

                                                           April 15, 2026

Eric Easom
President and Chief Executive Officer
AN2 Therapeutics, Inc.
1300 El Camino Real, Suite 100
Menlo Park, California 94025

       Re: AN2 Therapeutics, Inc.
           Registration Statement on Form S-3
           Filed April 9, 2026
           File No. 333-294956
Dear Eric Easom:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Chris Edwards at 202-551-6761 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Life
Sciences
cc:    Richard Kim

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._